BBBY Stock Price: Bed Bath & Beyond Inc hits two-year high, Trump's COVID-19 may trigger more gains
Premium|You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
Your coupon code
FXS75
- NASDAQ: BBBY has been extending its gains, looking toward a weekly close above $20.
- A robust earnings report continues propelling Bed Bath & Beyond.
- Trump's coronavirus illness may push to keep more Americans at home and support the stock.
The entire world is talking about the shocking news that President Donald Trump tested positive for coronavirus. According to the latest reports, the leader of the world's most powerful country is showing mild symptoms. The focus is set to remain on the president's health and those around him.
Trump has been playing down the virus and tried shifting the electoral campaign to other topics. He encouraged Americans to go out and about, touting a strong economy. Many have listened and ignored the threat. However, the president's illness may now refocus minds on the dangers of COVID-19.
How is that related to Bed Bath & Beyond? The retail store company sells products used in homes. If Americans spend more time within their dwellings, they may further purchase the company's products.
BBBY Stock News
NASDAQ: BBBY is already up thanks to coronavirus-related purchases. Shares leaped earlier in the week after Bed Bath and Beyond reported growth of 89% in digital sales. While it refused to provide guidance – also related to uncertainty related to the disease – investors seem confident.
Revenue hit $2.69 billion, marginal beating estimates of $2.62 million. The GAAP Earnings Per Share smashed projections with $1.75 against only one cent forecast.
Shares are on the rise once again, defying the downbeat direction in markets.
At the time of writing, NASDAQ: BBBY hit a fresh two-year high of $20.37, levels last seen in mid-2018. Bed Bath and Beyond has flown well beyond the $15/share range seen early in the week and is nearly double the levels seen early in the summer.
More Trump's coronavirus adds uncertainty in three ways, stocks have more room to fall
- NASDAQ: BBBY has been extending its gains, looking toward a weekly close above $20.
- A robust earnings report continues propelling Bed Bath & Beyond.
- Trump's coronavirus illness may push to keep more Americans at home and support the stock.
The entire world is talking about the shocking news that President Donald Trump tested positive for coronavirus. According to the latest reports, the leader of the world's most powerful country is showing mild symptoms. The focus is set to remain on the president's health and those around him.
Trump has been playing down the virus and tried shifting the electoral campaign to other topics. He encouraged Americans to go out and about, touting a strong economy. Many have listened and ignored the threat. However, the president's illness may now refocus minds on the dangers of COVID-19.
How is that related to Bed Bath & Beyond? The retail store company sells products used in homes. If Americans spend more time within their dwellings, they may further purchase the company's products.
BBBY Stock News
NASDAQ: BBBY is already up thanks to coronavirus-related purchases. Shares leaped earlier in the week after Bed Bath and Beyond reported growth of 89% in digital sales. While it refused to provide guidance – also related to uncertainty related to the disease – investors seem confident.
Revenue hit $2.69 billion, marginal beating estimates of $2.62 million. The GAAP Earnings Per Share smashed projections with $1.75 against only one cent forecast.
Shares are on the rise once again, defying the downbeat direction in markets.
At the time of writing, NASDAQ: BBBY hit a fresh two-year high of $20.37, levels last seen in mid-2018. Bed Bath and Beyond has flown well beyond the $15/share range seen early in the week and is nearly double the levels seen early in the summer.
More Trump's coronavirus adds uncertainty in three ways, stocks have more room to fall
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.